Hepatocyte injury in tyrosinemia type 1 is induced by fumarylacetoacetate and is inhibited by caspase inhibitors.
about
Curative ex vivo liver-directed gene therapy in a pig model of hereditary tyrosinemia type 1.Fumarylacetoacetate hydrolase deficient pigs are a novel large animal model of metabolic liver diseaseBlockade of caspases inhibits amebic liver abscess formation in a mouse model of disease.Hereditary tyrosinaemia type I: from basics to progress in treatment.Sustained phosphorylation of Bid is a marker for resistance to Fas-induced apoptosis during chronic liver diseases.Mechanisms of liver injury relevant to pediatric hepatology.Experience of nitisinone for the pharmacological treatment of hereditary tyrosinaemia type 1.A journey of hope: lessons learned from studies on rare diseases and orphan drugs.The Caenorhabditis elegans K10C2.4 gene encodes a member of the fumarylacetoacetate hydrolase family: a Caenorhabditis elegans model of type I tyrosinemia.Clinical and para clinical findings in the children with tyrosinemia referring for liver transplantation.Heat shock response associated with hepatocarcinogenesis in a murine model of hereditary tyrosinemia type I.A potential biomarker of kidney damage identified by proteomics: preliminary findings.Fumarate Mediates a Chronic Proliferative Signal in Fumarate Hydratase-Inactivated Cancer Cells by Increasing Transcription and Translation of Ferritin Genes.Molecular Pathogenesis of Liver Injury in Hereditary Tyrosinemia 1.
P2860
Q30856034-558CD37C-B8A2-4102-ACFB-9743824C8CF1Q33897291-9007A71B-4490-4034-9B37-C4D3FA755198Q34009927-96616E3E-C7E8-4C79-80C0-B3B18A04291AQ34111877-7A77FF6B-8E7F-4732-85E6-62369D88E748Q34504973-5A17BD8B-7A07-4CA8-889C-74459BF5BC0FQ34559789-F6DF9EAF-A126-418A-8654-EFE480FEA161Q34590786-88A40EDE-3FDC-4142-8A26-A40452AC06D5Q36514274-5C52890A-9403-4566-AA40-28E5AA637228Q36727248-743C78EC-5DB4-46FF-AD81-1B2B2918A44BQ37503025-84159282-AC3F-436F-92DA-E3C4D30B9FE5Q41457848-8043FCC3-BC5A-4FCC-8D8E-E502FDCD4157Q44565770-DD472575-2BE0-445C-B20A-CA7EB495B5A1Q45248744-210927CF-52E3-45A0-A0A4-6439A755DF3CQ50517224-3347C7E4-A40A-42A9-8AAB-94214C42C4F3
P2860
Hepatocyte injury in tyrosinemia type 1 is induced by fumarylacetoacetate and is inhibited by caspase inhibitors.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh
1998年學術文章
@zh-hant
name
Hepatocyte injury in tyrosinem ...... hibited by caspase inhibitors.
@ast
Hepatocyte injury in tyrosinem ...... hibited by caspase inhibitors.
@en
type
label
Hepatocyte injury in tyrosinem ...... hibited by caspase inhibitors.
@ast
Hepatocyte injury in tyrosinem ...... hibited by caspase inhibitors.
@en
prefLabel
Hepatocyte injury in tyrosinem ...... hibited by caspase inhibitors.
@ast
Hepatocyte injury in tyrosinem ...... hibited by caspase inhibitors.
@en
P2093
P2860
P356
P1476
Hepatocyte injury in tyrosinem ...... hibited by caspase inhibitors.
@en
P2093
Miyahara M
Yamamoto T
P2860
P304
P356
10.1073/PNAS.95.16.9552
P407
P577
1998-08-01T00:00:00Z